EU clears Elanco/Bayer with pipeline product divestments
The European Commission has approved Elanco’s $7.6 billion purchase of Bayer’s animal health business, subject to the divestment of existing and pipeline products in the pet and livestock pharmaceutical markets.
To read more
Subscribe to Global Competition Review
Subscribe to unlock unlimited access
Get news, unique commentary, expert analysis and essential resources from the Global Competition Review experts.